# Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen

> **NCT02285179** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 189 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** GDC-0032
- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT02285179
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2022-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285179, "Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02285179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*